Swedish researchers tracking down early diagnosis of Parkinson’s disease
The need for diagnostic biomarkers for degenerative disorders affecting the nervous system, such as Parkinson’s and Alzheimer’s, is great and acute. Early diagnosis of such diseases would enable treatment at a stage when they are most responsive to intervention, during the period when the greatest number of nerve cells are being damaged or dying. Research is underway around the world to develop substances that can affect the course of the disease.
What many neurodegenerative diseases have in common is that they are caused by proteins that lump together into so-called amyloid. Ludmilla Morozova-Roche’s research team has found endogenous antibodies against the most important amyloid-producing protein in Parkinson’s disease, antibodies that could function as a diagnostic marker for the disease. Monitoring the levels of endogenous antibodies in patients’ blood serum is simple and requires nothing more than a blood sample. This can become a method in clinical practice.
Ludmilla Morozova-Roche’s research is conducted in collaboration with Lars Forsgren, professor of neurology at Umeå University and chief physician at Norrlands University Hospital in Umeå, who is directing the research program on early diagnostics and monitoring of Parkinson’s patients. The findings indicate that autoimmunity may play a protective role in Parkinson’s disease. Immune reactions to the disease’s most significant amyloid-producing protein alpha synuclein may be of value in developing treatment strategies such as vaccination with amyloid antigens and antibodies, especially in the early stages of the disorder.
For more information, please contact Ludmilla Morozova-Roche, professor of medical biophysics at the Department of Medical Chemistry and Biophysics, Umeå University at phone: +46 (0)90-786 52 83 mobile: +46 (0)73-620 52 83
e-mail ludmilla.morozova-roche@medchem.umu.se
Pressofficer Bertil Born; +46-703 886058, bertil.born@adm.umu.se
Reference:
Kiran Yanamandra, Marina A. Gruden, Vida Casaite, Rolandas Meskys, Lars Forsgren, Ludmilla A. Morozova-Roche: α-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients PLoS One, Volume 6, Issue 4, e18513:
Media Contact
All latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
‘Smart’ contact lenses could someday enable wireless glaucoma detection
Most people with early-stage glaucoma don’t know they have it, even though early treatment is key to reducing vision loss. While detecting a subtle increase in eye pressure helps doctors…
New tech may lead to smaller, more powerful wireless devices
Good vibrations… What if your earbuds could do everything your smartphone can do already, except better? What sounds a bit like science fiction may actually not be so far off….
Caution, hot surface!
An international research team from the University of Jena and the Helmholtz Institute Jena are demystifying the mechanisms by which high-intensity laser pulses produce plasma on the surface of solids….
